Tocilizumab administration in a refractory case of COVID-19

被引：11

作者：

Dastan, Farzaneh ^{[1
,2
]}

Nadji, Seyed Alireza ^{[3
]}

Saffaei, Ali ^{[4
]}

Tabarsi, Payam ^{[5
]}

机构：

[1] Shahid Beheshti Univ Med Sci, Dept Clin Pharm, Tehran, Iran

[2] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Chron Resp Dis Res Ctr CRDRC, Tehran, Iran

[3] Shahid Beheshti Univ Med Sci, Virol Res Ctr, Natl Inst TB & Lung Dis NRITLD, Tehran, Iran

[4] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Clin Pharm, Student Res Comm, Tehran, Iran

[5] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Clin TB & Epidemiol Res Ctr, Daarabad St,Niyavaran St, Tehran 1956944413, Iran

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2020年 / 56卷 / 02期

关键词：

D O I：

10.1016/j.ijantimicag.2020.106043

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页数：3

共 7 条

[1] Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR (Publication with Expression of Concern) [J].

Corman, Victor M. ;

Landt, Olfert ;

Kaiser, Marco ;

Molenkamp, Richard ;

Meijer, Adam ;

Chu, Daniel K. W. ;

Bleicker, Tobias ;

Bruenink, Sebastian ;

Schneider, Julia ;

Schmidt, Marie Luisa ;

Mulders, Daphne G. J. C. ;

Haagmans, Bart L. ;

van der Veer, Bas ;

van den Brink, Sharon ;

Wijsman, Lisa ;

Goderski, Gabriel ;

Romette, Jean-Louis ;

Ellis, Joanna ;

Zambon, Maria ;

Peiris, Malik ;

Goossens, Herman ;

Reusken, Chantal ;

Koopmans, Marion P. G. ;

Drosten, Christian .

EUROSURVEILLANCE, 2020, 25 (03) :23-30

[2] Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study [J].

Gautret, Philippe ;

Lagier, Jean-Christophe ;

Parola, Philippe ;

Van Thuan Hoang ;

Meddeb, Line ;

Sevestre, Jacques ;

Mailhe, Morgane ;

Doudier, Barbara ;

Aubry, Camille ;

Amrane, Sophie ;

Seng, Piseth ;

Hocquart, Marie ;

Eldin, Carole ;

Finance, Julie ;

Vieira, Vera Esteves ;

Tissot-Dupont, Herve Tissot ;

Honore, Stephane ;

Stein, Andreas ;

Million, Matthieu ;

Colson, Philippe ;

La Scola, Bernard ;

Veit, Veronique ;

Jacquier, Alexis ;

Deharo, Jean-Claude ;

Drancourt, Michel ;

Fournier, Pierre Edouard ;

Rolain, Jean-Marc ;

Brouqui, Philippe ;

Raoult, Didier .

TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 34

[3]

Hammami MB, 2020, CLIN COURSE COVID 19

[4] The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan [J].

Lim, Chong Hong ;

Chen, Hsin-Hua ;

Chen, Yi-Hsing ;

Chen, Der-Yuan ;

Huang, Wen-Nan ;

Tsai, Jaw-Ji ;

Hsieh, Tsu-Yi ;

Hsieh, Chia-Wei ;

Hung, Wei-Ting ;

Lin, Ching-Tsai ;

Lai, Kuo-Lung ;

Tang, Kuo-Tung ;

Tseng, Chih-Wei ;

Chen, Yi-Ming .

PLOS ONE, 2017, 12 (06)

[5]

Sciascia S, 2020, CLIN EXP RHEUMATOL

[6] Effective treatment of severe COVID-19 patients with tocilizumab [J].

Xu, Xiaoling ;

Han, Mingfeng ;

Li, Tiantian ;

Sun, Wei ;

Wang, Dongsheng ;

Fu, Binqing ;

Zhou, Yonggang ;

Zheng, Xiaohu ;

Yang, Yun ;

Li, Xiuyong ;

Zhang, Xiaohua ;

Pan, Aijun ;

Wei, Haiming .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (20) :10970-10975

[7] Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality [J].

Zhang, Chi ;

Wu, Zhao ;

Li, Jia-Wen ;

Zhao, Hong ;

Wang, Gui-Qiang .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (05)

← 1 →